These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia. Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733 [TBL] [Abstract][Full Text] [Related]
6. [Levodopa and cognitive disorders in Parkinson's disease]. Leiva-Santana C; Alvarez-Saúco M Rev Neurol; 2006 Jul 16-31; 43(2):95-100. PubMed ID: 16838257 [TBL] [Abstract][Full Text] [Related]
7. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
8. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model. de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500 [TBL] [Abstract][Full Text] [Related]
9. Update on the treatment of Parkinson's disease. Wirz D Conn Med; 1985 Oct; 49(10):633-7. PubMed ID: 3933903 [No Abstract] [Full Text] [Related]
10. [Contribution to the biochemical treatment of the Parkinson's disease (author's transl)]. Calatayud Maldonado V Rev Esp Otoneurooftalmol Neurocir; 1978; 36(204):33-41. PubMed ID: 741072 [No Abstract] [Full Text] [Related]
11. [Drug therapy in Parkinson's disease]. van Hilten JJ; Roos RA Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151 [TBL] [Abstract][Full Text] [Related]
12. The neurochemistry of therapeutics: levodopa pharmacodynamics in Parkinson's disease. Frey KA Ann Neurol; 2001 Mar; 49(3):285-7. PubMed ID: 11261500 [No Abstract] [Full Text] [Related]